Hyaluronidase and trastuzumab and Insulin Degludec (U-200) Prefilled Pens
Determining the interaction of Hyaluronidase and trastuzumab and Insulin Degludec (U-200) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Trastuzumab and Hyaluronidase
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase and trastuzumab-Insulin degludec and liraglutide
- Hyaluronidase and trastuzumab-Insulin degludec and liraglutide Subcutaneous
- Hyaluronidase and trastuzumab-Insulin degludec Subcutaneous
- Hyaluronidase and trastuzumab-Insulin detemir
- Hyaluronidase and trastuzumab-Insulin Detemir (Cartridges and Prefilled Syringes)
- Hyaluronidase and trastuzumab-Insulin Detemir (Vials)
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronidase injection
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronidase Injection (Human)
- Insulin Degludec (U-200) Prefilled Pens-Hyaluronidase Subcutaneous, Injection
- Insulin Degludec (U-200) Prefilled Pens-Hyate:C
- Insulin Degludec (U-200) Prefilled Pens-Hybrisil
- Insulin Degludec (U-200) Prefilled Pens-Hycamtin